Reply to Le Turnier et al., "Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone"

Carmen Cabellos; Lluïsa Guillem; Ivan Pelegrin; Fe Tubau; Carmen Ardanuy; F Gudiol; J Ariza; Pedro F Viladrich

doi:10.1128/aac.00050-23

Reply to Le Turnier et al., "Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone"

Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0005023. doi: 10.1128/aac.00050-23. Epub 2023 Mar 7.

Authors

Carmen Cabellos^{1

2

3}, Lluïsa Guillem^{1

2

3}, Ivan Pelegrin^{1

2

3}, Fe Tubau^{4

5

6}, Carmen Ardanuy^{4

5

6}, F Gudiol^{1

2

3}, J Ariza^{1

2

3}, Pedro F Viladrich^{1

2

3}

Affiliations

¹ Infectious Diseases Department, Hospital Universitari Bellvitge-IDIBELL, L'Hospitalet de Llobregat, University of Barcelona, Barcelona, Spain.
² Centro de Investigación Biomédica de Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain.
³ Departament de Ciències Clíniques, University of Barcelona, Barcelona, Spain.
⁴ Microbiology Department, Hospital Universitari Bellvitge-IDIBELL, L'Hospitalet de Llobregat, University of Barcelona, Barcelona, Spain.
⁵ CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain.
⁶ Department of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Spain.

No abstract available

Publication types

Letter
Comment

MeSH terms

Cefotaxime / therapeutic use
Ceftriaxone / therapeutic use
Humans
Meningitis* / drug therapy
Meningitis, Bacterial* / drug therapy

Substances

Ceftriaxone
Cefotaxime